About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
90 genotypes with 90 annotations displayed of selected term and subterms
Searched Term: decreased metastatic potential
Allelic Composition
(Genetic Background)		 Annotated Term Reference
Anxa1tm1Rjf/Anxa1tm1Rjf
(involves: 129 * C57BL/6) 		decreased metastatic potential J:153690
Anxa1tm1Rjf/Anxa1tm1Rjf
Tg(MMTV-PyVT)634Mul/?
(involves: FVB/N) 		decreased metastatic potential J:174635
Atf3tm1.1Hai/Atf3tm1.1Hai
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * FVB/N) 		decreased metastatic potential J:201626
Atf3tm1Dron/Atf3tm1Dron
(involves: 129X1/SvJ * C57BL/6) 		decreased metastatic potential J:201626
Atf3tm1Dron/Atf3tm1Dron
Tg(MMTV-PyVT)634Mul/0
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		decreased metastatic potential J:201626
Bcl11btm1Peli/Bcl11btm1Peli
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6J) 		decreased metastatic potential J:161373
Casp1tm1Flv/Casp1tm1Flv
Casp4del/Casp4del
(involves: 129S2/SvPas) 		decreased metastatic potential J:59893
Ccdc25em1Smoc/Ccdc25em1Smoc
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6NTac * FVB/N) 		decreased metastatic potential J:291299
Ccm2ltm1Mlkn/Ccm2ltm1Mlkn
(involves: 129 * C57BL/6) 		decreased metastatic potential J:187714
Ccr5tm1Kuz/Ccr5tm1Kuz
Tg(CAG-EGFP)1Osb/?
(involves: 129P2/OlaHsd * C3H * C57BL/6) 		decreased metastatic potential J:97833
Cd1tm1Gru/Cd1tm1Gru
(involves: 129S2/SvPas * BALB/c) 		decreased metastatic potential J:118828
Cd44tm1Mak/Cd44tm1Mak
Trp53tm1Tyj/Trp53+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * C57BL/6J) 		decreased metastatic potential J:76201
Cd96tm1.1Mjs/Cd96tm1.1Mjs
(B6.129P2(Cg)-Cd96tm1.1Mjs) 		decreased metastatic potential J:209990
Cks1btm1Sir/Cks1btm1Sir
Tg(IghMyc)22Bri/?
(involves: C57BL * C57BL/6 * SJL) 		decreased metastatic potential J:121564
Cpt1cGt(XL823)Byg/Cpt1c+
Nf1tm1Tyj/Nf1+
Trp53tm1Tyj/Trp53+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		decreased metastatic potential J:228258
Ctsbtm1Jde/Ctsbtm1Jde
Ctsztm1Thre/Ctsztm1Thre
Tg(MMTV-PyVT)634Mul/0
(FVB.129P2-Ctsztm1Thre Ctsbtm1Jde Tg(MMTV-PyVT)634Mul) 		decreased metastatic potential J:157541
Ctsbtm1Jde/Ctsbtm1Jde
Tg(MMTV-PyVT)634Mul/0
(FVB.129P2-Ctsbtm1Jde Tg(MMTV-PyVT)634Mul) 		decreased metastatic potential J:157541
Ctsztm1Thre/Ctsztm1Thre
Tg(MMTV-PyVT)634Mul/0
(FVB.129P2-Ctsztm1Thre Tg(MMTV-PyVT)634Mul) 		decreased metastatic potential J:157541
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(B6.Cg-Il8rbtm1Mwm) 		decreased metastatic potential J:88233
Cybbtm1Din/Cybbtm1Din
(B6.129S-Cybbtm1Din) 		decreased metastatic potential J:110181
Ddr2tm1a(EUCOMM)Wtsi/Ddr2tm1a(EUCOMM)Wtsi
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6N * FVB/N) 		decreased metastatic potential J:236031
Ddr2tm1b(EUCOMM)Wtsi/Ddr2tm1b(EUCOMM)Wtsi
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6N * FVB/N) 		decreased metastatic potential J:236031
Ddr2tm1c(EUCOMM)Wtsi/Ddr2tm1c(EUCOMM)Wtsi
Tg(KRT14-cre)1Amc/0
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * C57BL/6N * CBA * FVB/N) 		decreased metastatic potential J:236031
Dock1tm2.1Jfco/Dock1tm2.1Jfco
Tg(MMTV-Erbb2*,-cre)1Mul/0
(involves: C57BL/6 * FVB/NJ) 		decreased metastatic potential J:196659
Epha2tm1Jrui/Epha2tm1Jrui
Krastm4Tyj/Kras+
Trp53tm2.1Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S/SvEv * 129S4/SvJae * FVB/N) 		decreased metastatic potential J:244261
Erbb3tm1.1(ERBB3)Mul/Erbb3tm1.1(ERBB3)Mul
Tg(MMTV-Erbb2*)NDL2-5Mul/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		decreased metastatic potential J:189292
Etv4tm1Hass/Etv4tm1Hass
Tg(MMTVneu)202Mul/Tg(MMTVneu)202Mul
(involves: FVB/N) 		decreased metastatic potential J:87017
Fbln5tm1Eno/Fbln5tm1Eno
(involves: 129S6/SvEvTac * C57BL/6) 		decreased metastatic potential J:159246
Flot2tm1Mak/Flot2tm1Mak
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		decreased metastatic potential J:203238
Fostm1Pa/Fostm1Pa
(involves: 129X1/SvJ * C57BL/6J) 		decreased metastatic potential J:78834
Foxn1nu/Foxn1nu
Gpc1tm1.1Alan/Gpc1tm1.1Alan
(involves: CD-1) 		decreased metastatic potential J:130809
Fut7tm1Jbl/Fut7tm1Jbl
(B6.129S2-Fut7tm1Jbl) 		decreased metastatic potential J:106671
Hcsttm1.1Dnax/Hcsttm1.1Dnax
(involves: C57BL/6) 		decreased metastatic potential J:148086
Hunktm1Lach/Hunk+
Tg(MMTV-Myc)#Led/0
(involves: 129P2/OlaHsd * C57BL/6J * CD-1) 		decreased metastatic potential J:153075
Hunktm1Lach/Hunktm1Lach
Tg(MMTV-Myc)#Led/0
(involves: 129P2/OlaHsd * C57BL/6J * CD-1) 		decreased metastatic potential J:153075
Id1tm1Zhu/Id1+
(involves: 129S1/Sv * 129S4/SvJaeSor) 		decreased metastatic potential J:86480
Id1tm1Zhu/Id1+
Id3tm1Zhu/Id3tm1Zhu
(involves: 129S1/Sv * 129S4/SvJaeSor) 		decreased metastatic potential J:86480
Ifngr1tm1.1Rost/Ifngr1tm1.1Rost
(involves: BALB/cJ * C57BL/6) 		decreased metastatic potential J:152785
Il1atm1Yiw/Il1atm1Yiw
(involves: 129S1/Sv * 129X1/SvJ) 		decreased metastatic potential J:82394
Il1btm1Lvp/Il1btm1Lvp
(involves: 129S7/SvEvBrd) 		decreased metastatic potential J:59893, J:82394
Inpp5jtm1.1Cmit/Inpp5jtm1.1Cmit
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6) 		decreased metastatic potential J:224914
Itgb1tm1Ref/Itgb1tm1Ref
Tg(Ins2-cre)1Heed/?
Tg(RIP1-Tag)2Dh/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * CBA * DBA/2J) 		decreased metastatic potential J:122649
Jam3tm1.1Chav/Jam3tm1.1Chav
Tg(Tal1-cre/ERT)1Jrg/?
(involves: 129 * C57BL/6) 		decreased metastatic potential J:173391
Jam3tm1.1Chav/Jam3tm1.2Chav
Tg(Cdh5-cre)7Mlia/?
(involves: 129 * C57BL/6 * FVB/N) 		decreased metastatic potential J:173391
Jam3tm1.2Chav/Jam3tm1.2Chav
(B6.129-Jam3tm1.2Chav) 		decreased metastatic potential J:173391
Kars1Gt(AJ0130)Wtsi/Kars1+
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * FVB/N) 		decreased metastatic potential J:264950
Krastm4Tyj/Kras+
Ptf1atm1.1(cre)Cvw/Ptf1a+
Tg(MUC1)79.24Gend/0
(B6.Cg-Krastm4Tyj Ptf1atm1.1(cre)Cvw Tg(MUC1)79.24Gend) 		decreased metastatic potential J:138959
Krastm4Tyj/Kras+
Rab11fip1tm1.1Jicn/Rab11fip1tm1.1Jicn
Tg(Pdx1-cre)6Tuv/0
Trp53tm2.1Tyj/Trp53+
(involves: 129S4/SvJae * FVB/N) 		decreased metastatic potential J:244261
Krastm4Tyj/Kras+
Trp53tm2Tyj/Trp53+
Zdhhc20em1Jdo/Zdhhc20em1Jdo
Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		decreased metastatic potential J:348743
Krastm4Tyj/Krastm4Tyj
Mir182tm1.1Dgk/Mir182+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129/Sv * 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		decreased metastatic potential J:217635
Krastm4Tyj/Krastm4Tyj
Mir182tm1.1Dgk/Mir182tm1.1Dgk
Trp53tm1Brn/Trp53tm1Brn
(involves: 129/Sv * 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		decreased metastatic potential J:217635
Lystbg-2J/Lystbg-2J
(C3.Cg-Lystbg-2J/J) 		decreased metastatic potential J:33522
Map3k1tm1Glj/Map3k1tm1Glj
Tg(MMTV-PyVT)634Mul/0
(involves: 129S/SvEv * FVB/N) 		decreased metastatic potential J:112298
Mfge8tm1Mcu/Mfge8tm1Mcu
Tg(RIP1-Tag)2Dh/?
(involves: 129X1/SvJ * C57BL/6J * C57BL/6NCr * DBA/2J) 		decreased metastatic potential J:123138
Mgat5tm1Jwd/Mgat5tm1Jwd
(involves: 129S1/Sv * 129X1/SvJ) 		decreased metastatic potential J:60960
Mir31em1Nju/Mir31em1Nju
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6J * FVB/N) 		decreased metastatic potential J:271420
Mmp9tm1Itoh/Mmp9tm1Itoh
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased metastatic potential J:55823
Mmp9tm1Tvu/Mmp9tm1Tvu
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6 * FVB/N) 		decreased metastatic potential J:140033
Mmp9tm1Tvu/Mmp9tm1Tvu
Tg(MMTV-PyVT)634Mul/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N) 		decreased metastatic potential J:140033
MtdhGt(XB780)Byg/MtdhGt(XB780)Byg
Tg(MMTV-PyVT)634Mul/0
(FVB.Cg-MtdhGt(XB780)Byg Tg(MMTV-PyVT)634Mul) 		decreased metastatic potential J:214244
MtdhGt(XB780)Byg/MtdhGt(XB780)Byg
Tg(MMTVneu)202Mul/0
(FVB.Cg-MtdhGt(XB780)Byg Tg(MMTVneu)202Mul) 		decreased metastatic potential J:214244
Nbeal2tm1a(EUCOMM)Wtsi/Nbeal2tm1a(EUCOMM)Wtsi
(C57BL/6N-Nbeal2tm1a(EUCOMM)Wtsi/Wtsi) 		decreased metastatic potential J:220801
Ncoa3tm1Jxu/Ncoa3tm1Jxu
Tg(MMTV-vHaras)SH1Led/0
(involves: 129S6/SvEvTac * C57BL/6J * CD-1) 		decreased metastatic potential J:88789
Plautm1Mlg/Plautm1Mlg
(B6.Cg-Plautm1Mlg) 		decreased metastatic potential J:65383
Pld1tm1.1Mafr/Pld1tm1.1Mafr
(B6.Cg-Pld1tm1.1Mafr) 		decreased metastatic potential J:193451
Plgtm1Jld/Plgtm1Jld
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * Black Swiss * FVB/N) 		decreased metastatic potential J:48285
Ptk2tm3.1Guan/Ptk2tm3.1Guan
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N) 		decreased metastatic potential J:195658
Rhoctm1Mak/Rhoctm1Mak
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * FVB/N) 		decreased metastatic potential J:100482
Rhojtm1.2Auem/Rhojtm1.2Auem
(B6.Cg-Rhojtm1.2Auem) 		decreased metastatic potential J:208154
Rhojtm1.2Auem/Rhojtm1.2Auem
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * CBA/JNCrlj * FVB/N) 		decreased metastatic potential J:208154
Rr149356tm1Che/Rr149356tm1Che
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		decreased metastatic potential J:106246
Saaem1.1Hiras/Saaem1.1Hiras
(involves: C57BL/6) 		decreased metastatic potential J:355692
Selltm2Hyn/Selltm2Hyn
(involves: 129S2/SvPas * C57BL/6) 		decreased metastatic potential J:106671
Setd4tm1c(KOMP)Wtsi/Setd4tm1c(KOMP)Wtsi
Trp53tm1Brn/Trp53tm1Brn
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6N) 		decreased metastatic potential J:297725
Shc1tm5Paw/Shc1+
Tg(MMTV-PyVT)634Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		decreased metastatic potential J:133325
Shc1tm5Paw/Shc1tm5Paw
Tg(MMTV-PyVT)634Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		decreased metastatic potential J:133325
Shc1tm6Paw/Shc1+
Tg(MMTV-PyVT)634Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		decreased metastatic potential J:133325
Shc1tm6Paw/Shc1tm6Paw
Tg(MMTV-PyVT)634Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		decreased metastatic potential J:133325
Shc1tm7Paw/Shc1+
Tg(MMTV-PyVT)634Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		decreased metastatic potential J:133325
Slc6a14tm1Gana/Slc6a14tm1Gana
Tg(MMTV-PyVT)634Mul/0
(Not Specified) 		decreased metastatic potential J:226105
Stab2tm1Ami/Stab2tm1Ami
(B6.Cg-Stab2tm1Ami) 		decreased metastatic potential J:182239
Stat6tm1Gru/Stat6tm1Gru
(C.129S2-Stat6tm1Gru) 		decreased metastatic potential J:65894
Tg(MMTV-PyVT)634Mul/0
(multiple strains) 		decreased metastatic potential J:48854
Tg(Tek-Npr1)#Kkan/0
(involves: C57BL/6) 		decreased metastatic potential J:220676
Tg(TRAMP)8247Ng/0
Tmprss2tm1Psn/Tmprss2tm1Psn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased metastatic potential J:217920
Tgfb1i1tm1.2Cet/Tgfb1i1tm1.2Cet
Tg(MMTV-PyVT)634Mul/0
(involves: 129S/SvEv * C57BL/6 * FVB/N) 		decreased metastatic potential J:241234
Tmem219tm1(KOMP)Vlcg/Tmem219tm1(KOMP)Vlcg
(B6J.B6N-Tmem219tm1(KOMP)Vlcg) 		decreased metastatic potential J:236976
Ube2otm1.1(KOMP)Mbp/Ube2otm1.1(KOMP)Mbp
Tg(TRAMP)8247Ng/0
(involves: C57BL/6 * C57BL/6N * FVB/N) 		decreased metastatic potential J:239679
Vegfatm2Gne/Vegfatm2Gne
Tg(Csf1r-cre/Esr1*)1Jwp/0
(involves: 129 * C57BL/6 * FVB/N) 		decreased metastatic potential J:186831
Vegfdtm1Hrl/Y
(B6.129S-Vegfdtm1Hrl) 		decreased metastatic potential J:153734
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
03/18/2025
MGI 6.24 		The Jackson Laboratory